Country: New Zealand
Language: English
Source: Medsafe (Medicines Safety Authority)
Metformin hydrochloride 500mg
Miro Healthcare Limited
Metformin hydrochloride 500 mg
500 mg
Film coated tablet
Active: Metformin hydrochloride 500mg Excipient: Colloidal silicon dioxide Hypromellose E-15 Macrogol 6000 Magnesium stearate Maize starch Povidone Propylene glycol Purified talc Purified water Sodium starch glycolate Titanium dioxide
Blister pack, PVC/PVdC/aluminium, 100 tablets
Prescription
Prescription
Wanbury Limited
To control hyperglycaemia in metformin responsive, stable, mild, non-ketosis prone, maturity onset type of diabetes (Type II) which cannot be controlled by proper dietary management, exercise and weight reduction or when insulin therapy is not appropriate. It may be used alone or in combination with sulphonylurea therapy. Metformin can be of value for the treatment of obese diabetics. It may also be used as adjuvant therapy in insulin-dependent diabetics especially if they are overweight.
Package - Contents - Shelf Life: Blister pack, PVC/PVdC/aluminium - 100 tablets - 36 months from date of manufacture stored at or below 30°C - Bottle, plastic, 750 cc HDPE containers, induction sealed and wadded 53 mm screw caps - 1000 tablets - 36 months from date of manufacture stored at or below 30°C
2009-05-13
CONSUMER MEDICINE INFORMATION METFORMIN GENERIC HEALTH _metformin hydrochloride _ 500 mg and 850 mg tablets WHAT IS IN THIS LEAFLET Please read this leaflet carefully before you start using Metformin Generic Health. This leaflet answers some common questions about Metformin Generic Health. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Metformin Generic Health against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. Keep this leaflet with the medicine. You may need to read it again. WHAT METFORMIN GENERIC HEALTH IS USED FOR Metformin Generic Health is used to control high blood glucose level (the amount of sugar in the blood) in people with type 2 diabetes mellitus. This type of diabetes is also called non-insulin- dependent diabetes mellitus (NIDDM) or maturity onset diabetes. Metformin Generic Health is used when diet and exercise have not been enough to control your blood glucose. It can be used alone, or together with other medicines for treating diabetes. Metformin Generic Health contains the active ingredient metformin hydrochloride which belongs to a group of medicines called biguanides. It works by reducing liver glucose (sugar) production, improving insulin sensitivity in the muscles and slowing down the absorption of glucose from the intestinal tract. Your doctor may have prescribed Metformin Generic Health for another reason. Ask your doctor if you have any questions about why Metformin Generic Health has been prescribed for you. This medicine is available only with a doctor's prescription. Metformin Generic Health is not recommended for use in children. BEFORE YOU TAKE METFORMIN GENERIC HEALTH _WHEN YOU MUST NOT TAKE IT _ DO NOT TAKE METFORMIN GENERIC HEALTH IF YOU HAVE AN ALLERGY TO: • any medicine containing metformin hydrochloride or a class of medicines calle Read the complete document
1 | P a g e NEW ZEALAND DATA SHEET 1. PRODUCT NAME Indoco Metformin 500mg Film Coated Tablet Indoco Metformin 850mg Film Coated Tablet Film Coated Tablet 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Indoco Metformin 500mg Film Coated Tablet contains 500mg metformin hydrochloride. Indoco Metformin 850mg Film Coated Tablet contains 850mg metformin hydrochloride. For a full list of excipients, see _Section 6.1_. 3. PHARMACEUTICAL FORM Indoco Metformin500mg Film Coated Tablet: white to off white, circular, biconvex film coated tablet with beveled edges. Indoco Metformin 850mg Film Coated Tablet: white to off white, circular, biconvex film coated tablet with beveled edges. 4. CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS To control hyperglycemia in metformin responsive, stable, mild, non‐ketosis prone, maturity onset type of diabetes (Type II) which cannot be controlled by proper dietary management, exercise and weight reduction or when insulin therapy is not appropriate. It may be used alone or in combination with sulphonyl urea therapy. • Metformin can be of value for the treatment of obese diabetics. • It may also be used as adjuvant therapy in insulin‐dependent diabetics especially if they are overweight. 4.2. DOSE AND METHOD OF ADMINISTRATION This product may not be interchangeable with other products containing this ingredient in the New Zealand market. LIFE THREATENING LACTIC ACIDOSIS CAN OCCUR DUE TO ACCUMULATION OF METFORMIN. RISK FACTORS INCLUDE RENAL IMPAIRMENT, OLD AGE AND DOSES OF METFORMIN ABOVE 2 G PER DAY _(SEE SECTION _ _4.4)._ 2 | P a g e DOSE _ADULTS_ It is important that the tablets are taken in divided doses with meals. _MONOTHERAPY AND COMBINATION WITH OTHER ORAL ANTIDIABETIC AGENTS IN ADULTS WITH NORMAL _ _RENAL FUNCTION_ Initially 500 mg should be taken once or twice a day and, if necessary, increased over a few weeks up to a maximum of 1 g three times per day. The dose should be titrated with gradual dose increments until the desired effect is obtained. 500 mg three times a day is o Read the complete document